Skip to content

Ammonia

VARIOUS

FDA approvedATC V09GX05

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Ammonia is a drug catalogued in DrugCentral. Recorded indications include Acne vulgaris, Disorder of keratinization, Pityriasis simplex and Psoriasis.

  • Indications: Acne vulgaris, Disorder of keratinization, Pityriasis simplex, Psoriasis and Seborrheic dermatitis.
  • ATC code: V09GX05 (Other cardiovascular system diagnostic radiopharmaceuticals).
  • Molecular formula: H3N; molecular weight 17.03 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (5)

  • Acne vulgaris
  • Disorder of keratinization
  • Pityriasis simplex
  • Psoriasis
  • Seborrheic dermatitis

Contraindications (7)

  • Blister
  • Condyloma acuminatum
  • Diabetes mellitus
  • Infection of skin AND/OR subcutaneous tissue
  • Inflammatory dermatosis
  • Peripheral vascular disease
  • Skin irritation

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA——

ATC classification

ATC codeTherapeutic hierarchy
V09GX05VARIOUS › DIAGNOSTIC RADIOPHARMACEUTICALS › CARDIOVASCULAR SYSTEM › Other cardiovascular system diagnostic radiopharmaceuticals

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Ammonia is on its molecule page.

Molecular formulaH3N
Molecular weight17.03 g/mol
CAS number7664-41-7
InChIKeyQGZKDVFQNNGYKY-UHFFFAOYSA-N
PubChem CID222
N

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Ammonia used for?

DrugCentral lists the following indications for Ammonia: Acne vulgaris, Disorder of keratinization, Pityriasis simplex, Psoriasis and Seborrheic dermatitis.

What is the chemical formula of Ammonia?

Ammonia has the molecular formula H3N and a molecular weight of 17.03 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyFDA
Targets0
Indications5
FormulaH3N
DrugCentral ID4625
Interactive profile